Yuan Cheng,1,* Qingqing Wang,2,* Guihong Niu,1 Chun Luo3 1Medical School, Fuyang Normal University, Fuyang, Anhui, People’s Republic of China; 2Department of Neurology, The Affiliated Fuyang People’s Hospital of Anhui Medical University, Fuyang ...
Cheng Y, Wang Q, Niu G, Luo C
doaj
Clinical Recovery from Acute Ischemic Stroke after Early Reperfusion of the Brain with Intravenous Thrombolysis [PDF]
Andrew M. Demchuk+2 more
openalex +1 more source
Background Hyperacute ischemic stroke is a type of ischemic stroke that occurs rapidly and suddenly due to blockage of blood flow to the brain, with onset within 0–24 h.
Lisda Amalia, Putri Qonitah
doaj +1 more source
Acute central retinal vein occlusion successfully treated with intravenous thrombolysis [PDF]
Mark Costen+2 more
openalex +1 more source
Intravenous thrombolysis is an effective treatment for acute ischemic stroke. The ESO recommends that tenecteplase be used for thrombolytic therapy in stroke within 4.5h of onset.
Sisi Zhao+3 more
doaj
Lack of Benefit for Intravenous Thrombolysis in Patients With Myocardial Infarction Who Are Older Than 75 Years [PDF]
David R. Thiemann+5 more
openalex +1 more source
Monitoring Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke With Diffusion and Perfusion MRI [PDF]
Peter D. Schellinger+9 more
openalex +1 more source
Stent-Assisted Endovascular Thrombolysis Versus Intravenous Thrombolysis in Internal Carotid Artery Dissection With Tandem Internal Carotid and Middle Cerebral Artery Occlusion [PDF]
Philippa C. Lavallée+7 more
openalex +3 more sources
Introduction The present study focused on developing a nomogram model to predict the 3-month survival of patients with acute ischemic stroke (AIS) receiving intravenous thrombolysis with tissue plasminogen activator (tPA).
Ynglei Li, Ning Li, Lingyun Xi, Litao Li
doaj +1 more source
Lessons learned from multicenter randomized clinical trials with intravenous thrombolysis for acute ischemic stroke [PDF]
Christopher Lewandowski+1 more
openalex +1 more source